Novartis (NVS)
(Delayed Data from NYSE)
$115.94 USD
-0.04 (-0.03%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $116.16 +0.22 (0.19%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth B Momentum C VGM
Industry / Sector Report
Industry : Large Cap Pharmaceuticals
Zacks Industry Rank
Top 31% (79 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 3.00 | 2.05 | 9.99 |
Current Quarter Estimate | 1.92 | 37.63 | 61.00 |
Year Ago Quarter Estimate | 1.74 | 12.41 | 54.84 |
Next Quarter Estimate | 1.87 | 38.42 | 63.00 |
Next Year Estimate | 8.29 | 173.72 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 8.70 | 6.60 | 15.67 |
Next Year | 10.53 | 16.80 | 11.34 |
Last 5 Years | 6.40 | 2.90 | 8.10 |
Next 5 Years | 8.90 | 11.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 16.47 | 22.31 |
Price/Book (MRQ) | 5.66 | 5.89 |
Price/Cash Flow (MRFY) | 10.43 | 12.20 |
Dividend Yield | 2.10% | 2.13% |
Net Profit Margin (TTM) | 33.76% | 18.86% |
Return on Equity (TTM) | 34.56% | 34.56% |
Debt to Equity (MRQ) | 0.47 | 40.19 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.